Intra-Cellular Therapies, Inc. (ITCI)
NASDAQ: ITCI · Real-Time Price · USD
85.64
+2.29 (2.75%)
Nov 20, 2024, 4:00 PM EST - Market closed
Intra-Cellular Therapies Market Cap
Intra-Cellular Therapies has a market cap or net worth of $9.08 billion as of November 21, 2024. Its market cap has increased by 67.75% in one year.
Market Cap
9.08B
Enterprise Value
8.09B
1-Year Change
67.75%
Ranking
Category
Stock Price
$85.64
Market Cap Chart
Since January 7, 2014, Intra-Cellular Therapies's market cap has increased from $332.00M to $9.08B, an increase of 2,634.73%. That is a compound annual growth rate of 35.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 9.08B | 31.73% |
| Dec 29, 2023 | 6.89B | 37.53% |
| Dec 30, 2022 | 5.01B | 17.54% |
| Dec 31, 2021 | 4.26B | 67.27% |
| Dec 31, 2020 | 2.55B | 34.44% |
| Dec 31, 2019 | 1.90B | 204.19% |
| Dec 31, 2018 | 623.30M | -21.13% |
| Dec 29, 2017 | 790.30M | 21.04% |
| Dec 30, 2016 | 652.90M | -71.79% |
| Dec 31, 2015 | 2.31B | 345.98% |
| Dec 31, 2014 | 518.90M | 56.30% |
| Jan 7, 2014 | 332.00M | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Qiagen | 9.07B |
| Bio-Rad Laboratories | 9.05B |
| Bio-Rad Laboratories | 8.98B |
| Teleflex | 8.97B |
| HealthEquity | 8.97B |
| Masimo | 8.75B |
| Tempus AI | 8.50B |
| Roivant Sciences | 8.23B |